Albert Bourla, DVM, Ph.D., Chief Executive Officer of Pfizer appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: Chris Kleponis/CNP /MediaPunch

- Image ID: RRR4A9

Albert Bourla, DVM, Ph.D., Chief Executive Officer of Pfizer appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: Chris Kleponis/CNP /MediaPunch

MediaPunch Inc / Alamy Stock Photo

Image ID: RRR4A9